Strategy& Insider

Strategy& Insider

Exploring future trends and their impacts

Strategy& Insider Episode 9 - Revolutionizing diagnostics with digital biomarkers

Download it: MP3 | AAC | OGG | OPUS

The ninth episode brings you ever closer to the future of healthcare with Thomas discussing the possibilities of digital biomarkers for modern medicine with Dan Vahdat, founder and CEO of Huma (formerly: Medopad). Together, they shed light on the prospect of diagnosing diseases in the earliest stages and how this contributes to a more preventative and personalized care for patients.

Comments

New comment

By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.

The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.

Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.

by Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch

Subscribe

Follow us

PwC Strategy& (Germany) GmbH